These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33589447)

  • 1. Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso.
    Siribie M; Tchouatieu AM; Soulama I; Kaboré JMT; Nombré Y; Hien D; Kiba Koumaré A; Barry N; Baguiya A; Héma A; Dianda F; Savadogo Y; Kouanda S; Tiono AB; Sirima SB
    BMJ Open; 2021 Feb; 11(2):e040220. PubMed ID: 33589447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
    Hien D; Kaboré JMT; Siribié M; Soulama I; Barry N; Baguiya A; Tiono AB; Tchouatieu AM; Sirima SB
    Malar J; 2022 Jun; 21(1):202. PubMed ID: 35761273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso.
    Kaboré JMT; Siribié M; Hien D; Soulama I; Barry N; Nombré Y; Dianda F; Baguiya A; Tiono AB; Burri C; Tchouatieu AM; Sirima SB
    Malar J; 2022 May; 21(1):155. PubMed ID: 35637506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of
    Djimde M; Tshiongo JK; Muhindo HM; Tinto H; Sevene E; Traore M; Vala A; Macuacua S; Kabore B; Dabira ED; Erhart A; Diakite H; Keita M; Piqueras M; González R; Menendez C; Dorlo TP; Sagara I; Mens P; Schallig H; D'Alessandro U; Kayentao K
    BMJ Open; 2023 Oct; 13(10):e065295. PubMed ID: 37813539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial.
    Tinto H; Diallo S; Zongo I; Guiraud I; Valea I; Kazienga A; Kpoda H; Sorgho H; Ouédraogo JB; Guiguemdé TR; D'Alessandro U
    Trop Med Int Health; 2014 Apr; 19(4):469-75. PubMed ID: 24494602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
    Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
    Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
    Zongo I; Dorsey G; Rouamba N; Tinto H; Dokomajilar C; Guiguemde RT; Rosenthal PJ; Ouedraogo JB
    Lancet; 2007 Feb; 369(9560):491-8. PubMed ID: 17292769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso.
    Kaboré JMT; Siribié M; Hien D; Soulama I; Barry N; Baguiya A; Tiono AB; Burri C; Tchouatieu AM; Sirima SB
    Trop Med Infect Dis; 2023 Mar; 8(4):. PubMed ID: 37104321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of effectiveness of two different artemisinin-based combination therapies in an area with high seasonal transmission of malaria in Burkina Faso.
    Sondo P; Derra K; Nakanabo SD; Tarnagda Z; Kazienga A; Valea I; Sorgho H; Ouédraogo JB; Guiguemdé TR; Tinto H
    Ann Parasitol; 2017; 63(2):127-131. PubMed ID: 28822205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.
    Sondo P; Derra K; Diallo-Nakanabo S; Tarnagda Z; Zampa O; Kazienga A; Valea I; Sorgho H; Owusu-Dabo E; Ouedraogo JB; Guiguemde TR; Tinto H
    Malar J; 2015 Aug; 14():325. PubMed ID: 26289949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
    Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC
    BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.
    Compaoré YD; Zongo I; Somé AF; Barry N; Nikiéma F; Kaboré TN; Ouattara A; Kabré Z; Wermi K; Zongo M; Yerbanga RS; Sagara I; Djimdé A; Ouédraogo JB
    Malar J; 2021 Jan; 20(1):64. PubMed ID: 33514368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso.
    Rouamba T; Sondo P; Derra K; Nakanabo-Diallo S; Bihoun B; Rouamba E; Tarnagda Z; Kazienga A; Valea I; Sorgho H; Pagnoni F; Samadoulougou-Kirakoya F; Tinto H
    Drug Des Devel Ther; 2020; 14():1507-1521. PubMed ID: 32368010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
    ; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
    N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
    Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
    Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open randomized controlled trial to compare the efficacy of two fixed dose combinations of artemesinin based combinations for uncomplicated falciparum malaria in Bangladesh.
    Samad R; Rahman MR; Yunus EB; Hussain MA; Arif SM; Islam MN; Hafiz SA; Hossain MM; Faiz MA
    Bangladesh Med Res Counc Bull; 2013 Dec; 39(3):109-15. PubMed ID: 26118157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.
    Lula Ntamba Y; Muhindo Mavoko H; Kalabuanga M; Fungula B; Ntamabyaliro Nsengi PM; Tona Lutete G; Inocencio da Luz R; Van Geertruyden JP; Lutumba P
    PLoS One; 2019; 14(9):e0222379. PubMed ID: 31527899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya.
    Osoro CB; Dellicour S; Ochodo E; Young T; Ter Kuile F; Gutman JR; Hill J
    Malar J; 2023 Sep; 22(1):262. PubMed ID: 37679753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.